Araknitek

Summary

Araknitek is an unverified lead associated with Utah State University spider-silk research. Spider silk could matter as a strong, elastic biomaterial, but this page cannot establish that Araknitek operated, commercialized it, or produced any impact attributable to the company.

Impact

The material case for spider silk is not in dispute — tensile strength per unit weight above steel, elasticity above Kevlar, and biocompatibility — and Lewis, who first cloned a spider silk protein in 1990 and later produced it in goats, silkworms, E. coli, and alfalfa, built one of the most cited programs in the field. The commercially interesting turn Araknitek was formed around is narrower and more surprising: once recombinant spider silk protein could be solubilized in water alone, it worked as an adhesive. The NSF I-Corps abstract records it bonding silicone, Teflon, polyurethane, stainless steel, and wood, "outperform[ing] both Elmer's wood glue and Gorilla glue," with the wood often failing before the joint did. The team's hypothesis was that biomedical adhesives — surgical glue and coatings — were the best market fit, with green industrial adhesives as a second.

What Araknitek itself displaced is the question the ladder asks, and the answer looks like very little. Rank the page's own subject: this is the company, not the science and not Lewis's career. A $50,000 I-Corps grant, a licence to a strong university platform, and no visible product, funding round, or customer is a real attempt that stopped at the walls of its own building. Spider silk commercialization has been a decade-plus graveyard sector-wide — the difficulty is not specific to USU — and whatever ceiling Araknitek once had is now bounded by the fact that it does not appear to be operating.

What They Are Building

The model was to supply bulk quantities of synthetic spider silk protein plus access to proprietary production processes, licensing customers to make and sell market-specific materials, devices, or goods — a protein supplier rather than a product company. Reported target applications spanned surgical sutures and adhesives, medical coatings and scaffolds, high-performance fibers, and ballistic materials. The binding constraint was always production economics: getting recombinant protein cheap enough and plentiful enough to compete with existing synthetics.

What They Need Now

Nothing verifiable — there is no evidence of an operating company to join. A reader drawn to this work should look instead to Utah State's ongoing program: the Lewis lab and USU's Innovation Campus bioproducts scale-up facility are where the science and the manufacturing capacity now live.

Who Could Help

If the entity were revived or its licence reassigned, the load-bearing needs would be fermentation and downstream-processing partners who can move recombinant protein into bulk production, biomedical-device customers able to qualify a novel adhesive, and non-dilutive funding from NIH or DoD for the surgical and protective-materials applications.

Utah Context

Utah State University in Logan hosts one of the world's most distinctive recombinant spider silk programs, and Araknitek was the 2012 vehicle for pushing it into products; the company's listed address, 1780 N Research Park Way in North Logan, is USU's research park. The commercialization path since has run through other channels — Lewis and Roberto Velozzi formed Spidey Tek in 2015, which announced a USU spider silk agreement in 2018, and USU has since broken ground on an Innovation Campus bioproducts scale-up facility. Araknitek is a useful case for how a university spinout can be superseded by later vehicles while the underlying research program keeps going.

Evidence

• NSF Award 1628245, "I-Corps: Araknitek — Synthetic Spider Silk Adhesives" · https://www.nsf.gov/awardsearch/showAward?AWD_ID=1628245 — $50,000 to Utah State University, awarded 2016-02-16, expired 2017-07-31; the adhesive performance claims and the biomedical market hypothesis quoted above are from its abstract.
• "USU's Spider Silk Lab Spinning Webs of Commercialization," Utah Policy · https://utahpolicy.com/archive/1702-usu-s-spider-silk-lab-spinning-webs-of-commercialization — the 2012 founding as a USU spin-out and the bulk-protein-plus-licence business model.
• "Spider-Man Can: USU Scientist says Synthetic Spider Silk Research Advancing," Utah State University · https://www.usu.edu/today/story/spider-man-can-usu-scientist-says-synthetic-spider-silk-research-advancing — Lewis's 1990 protein cloning and the four production hosts.
• "Spidey Tek and Utah State University Unite on Real Spider Silk," PR Newswire, 2018 · https://www.prnewswire.com/news-releases/spidey-tek-and-utah-state-university-unite-on-real-spider-silk-300626981.html — the later, separate commercialization vehicle.
• "USU Innovation Campus Breaks Ground on Bioproducts Scale-Up Facility," Utah State University · https://www.usu.edu/today/story/usu-innovation-campus-breaks-ground-on-bioproducts-scale-up-facility
• Official Website: Araknitek — records that no official website has been verified.

See Also

Open Questions

• Operating status is the load-bearing gap. araknitek.com returns no response, no activity is visible after the 2017 I-Corps expiration, and a commercial database lists the company as deadpooled — a weak source for a claim this central. A Utah Division of Corporations registration check would settle it and has not been done.
• Was the USU licence formally terminated, transferred to Spidey Tek, or simply left dormant? The relationship between the two entities is undocumented here.
• Did Araknitek ever raise private capital or win SBIR/STTR funding in its own name? Nothing found; the only award traced is the I-Corps grant, which went to USU rather than to the company.
• Which entity, if any, currently holds commercial rights to the Lewis lab's recombinant spider silk processes?
• No public careers or jobs page was found, consistent with the company being inactive.